Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commish Nominee Crawford Placed On Hold After Clearing Panel

This article was originally published in The Gray Sheet

Executive Summary

Senate confirmation of FDA Commissioner-designee Lester Crawford continues to prove a complicated matter, despite the Health Committee's June 15 approval

You may also be interested in...



Senate Confirms Crawford As FDA Commissioner In 78-16 Vote

Lester Crawford's nomination to be FDA's permanent commissioner cleared the Senate July 18 by a vote of 78-16

Senate Confirms Crawford As FDA Commissioner In 78-16 Vote

Lester Crawford's nomination to be FDA's permanent commissioner cleared the Senate July 18 by a vote of 78-16

Crawford hold lifted

Democratic Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) remove their hold on the nomination of FDA Acting Commissioner Lester Crawford to the permanent post on news that FDA will issue a decision on switching thePlan B emergency contraceptive to over-the-counter use by Sept. 1. Sen. Tom Coburn (R-Okla.) also has removed his hold related to condom labeling regulations, according to his office (1"The Gray Sheet" June 20, 2005, p. 11)...

UsernamePublicRestriction

Register

OM005385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel